Skip to main content
CDC Website

TB Prevention

Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (R01 Clinical Trial Not Allowed)

The purpose of this notice of funding opportunity (NOFO) is to support the evaluation of early-stage diagnostics and novel diagnostic strategies for Tuberculosis (TB) in the context of existing clinical algorithms in TB endemic countries.

TB Elimination Alliance Fact Sheet

This fact sheet provides an overview what the TB Elimination Alliance is, what it does, and the mini-grant program's efforts.

Latent Tuberculosis Infection Treatment At a Glance: 2023

The Latent Tuberculosis Infection Treatment at a Glance toolkit provides an overview of the coverage of key latent TB infection services in Massachusetts. The at-a-glance summarizes coverage for silver-level Qualified Health Plans (QHPs), ConnectorCare plans, and Medicaid (MassHealth) plans.

UNIVERSAL HEALTH CARE PROJECT APS

The U.S. Agency for International Development (USAID) Mission in the Philippines is pleased to announce the Universal Health Care Project (UHCP) Annual Program Statement (APS), which will improve health outcomes of underserved and vulnerable Filipinos in alignment with the United States Government (USG), USAID, and Philippine government objectives to achieve Universal Health Care (UHC). The UHCP is a suite of awards built to strategically improve national and local health systems in the Philippines across an integrated health portfolio.

Pulmonary Outcomes and Sequelae after Treatment-TB (POST-TB) (R01 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to support applications for epidemiological and observational research projects on the long-term cardiopulmonary sequelae following treatment for tuberculosis (TB). Investigators should propose additional testing and data collection in existing cohorts of adult and/or pediatric TB participants to better characterize and understand adverse outcomes and morbidity associated with TB disease post treatment in individuals with and without HIV infection.

Everyone has the right to access tuberculosis prevention

TB is preventable and treatable, and the world has set the objective of ending the disease by 2030. TB preventive treatment is one of the best ways to keep individuals and families safe from TB, which in turn helps communities become—and remain—TB free. Read more in this report.

Fight TB: Know the signs and symptoms

Since January of 2016, we have seen an increase of multidrug-resistance tuberculosis (MDR TB) in Minnesota. The severe increase in these rates is due to an MDR TB outbreak within the Hmong community of the east metro. What is very concerning about this outbreak is that it is not regular TB, but MDR TB. This means some of the typical medicines used to treat TB do not work, and we need to use stronger medications over a long period of time to get rid of the disease.